Furue Masutaka, Furue Mihoko
Kyushu University, Higashiku, Fukuoka 812-8582, Japan.
Independent Scholar, 1-19-20 Momochi, Sawara-ku, Fukuoka 814-0006, Japan.
J Clin Med. 2021 Apr 28;10(9):1906. doi: 10.3390/jcm10091906.
Skin inflammation often evokes pruritus, which is the major subjective symptom in many inflammatory skin diseases such as atopic dermatitis and prurigo nodularis. Pruritus or itch is a specific sensation found only in the skin. Recent studies have stressed the pivotal role played by interleukin-31 (IL-31) in the sensation of pruritus. IL-31 is produced by various cells including T helper 2 cells, macrophages, dendritic cells and eosinophils. IL-31 signals via a heterodimeric receptor composed of IL-31 receptor A (IL-31RA) and oncostatin M receptor β. Recent clinical trials have shown that the anti-IL-31RA antibody nemolizumab can successfully decrease pruritus in patients with atopic dermatitis and prurigo nodularis. The IL-31 pathway and pruritic skin are highlighted in this review article.
皮肤炎症常引发瘙痒,这是许多炎症性皮肤病(如特应性皮炎和结节性痒疹)的主要主观症状。瘙痒是一种仅在皮肤中出现的特殊感觉。最近的研究强调了白细胞介素-31(IL-31)在瘙痒感觉中所起的关键作用。IL-31由多种细胞产生,包括辅助性T细胞2、巨噬细胞、树突状细胞和嗜酸性粒细胞。IL-31通过由IL-31受体A(IL-31RA)和抑瘤素M受体β组成的异二聚体受体发出信号。最近的临床试验表明,抗IL-31RA抗体奈莫利珠单抗可成功减轻特应性皮炎和结节性痒疹患者的瘙痒症状。本文综述重点介绍了IL-31信号通路与瘙痒性皮肤。